Published: Wednesday, July 24, 2024 · 9:02 AM | Updated: Wednesday, July 24, 2024 · 9:02 AM
📊 430 views
Jul 23, 2024 / 12:30PM GMT
Operator
Good day and thank you for standing by. Welcome to Kiniksa Pharmaceuticals second-quarter 2024 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I will now hand the conference over to your speaker host for today, Rachel Frank, Head of Investor Relations. Please go ahead.
Rachel Frank – Kiniksa Pharmaceuticals Ltd – Head of Investor Relations
Thank you, operator. Good morning, everyone, and thank you for joining Kiniksa’s call to discuss our second-quarter 2024 financial results and recent portfolio execution. A press release highlighting these results can be found in our website under the Investors section.
As for the agenda, our Chief Executive Officer, Sanj K. Patel, will start with an introduction. Next Ross Moat, our Chief Commercial Officer, will provide an update on the ARCALYST commercial execution. From there, Mark Ragosa, our Chief Financial Officer, will review our second-quarter 2024 financial results. And finally, Sanj will return for closing remarks and to kick off the Q&A
MORE IN INSIDE INVESTMENT NEWS
Lululemon stock Plunges 20%: A Portfolio Warning for Retail Investors
Published: Friday, September 4, 2026 · 9:21 AM
Broadcom’s AI Growth: Alpha Potential in Next-Gen Chips
Published: Thursday, September 3, 2026 · 12:35 AM
